Sharescart Research Club logo ×
Screener Research Buy Unlisted Shares Sell Unlisted Shares Startup Funding New IPO New

  • Home
  • /
  • Sanofi India
Join Channel
Consolidated Standalone

Sanofi India

₹5911 -93.7 | 1.6%

Market Cap ₹13613 Cr.

Stock P/E 43.4

P/B 17.2

Current Price ₹5911

Book Value ₹ 343.5

Face Value 10

52W High ₹7593.6

Dividend Yield 1.98%

52W Low ₹ 4145.9

Edit Ratio

Sanofi India Research see more...

Overview Inc. Year: 1956Industry: Pharmaceuticals & Drugs

Sanofi India Ltd manufactures and trades in capsules and pharmaceutical products in India, Singapore and internationally. It presents pharmaceutical merchandise in diverse therapeutic areas, which include diabetes, cardiology, thrombosis, critical nervous machine, anti-infective, epilepsy, hypersensitive reaction and vitamins, anti-histamines, and minerals and supplements underneath the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands thru independent distributors. The business enterprise additionally exports its products. The organisation was formerly called Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Ltd is a subsidiary of Hoechst GmbH.

Read More..

Sanofi India Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Sanofi India Quarterly Results

#(Fig in Cr.) Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Net Sales 515 491 469 732 464 524 515
Other Income 16 11 9 7 5 2 6
Total Income 530 501 479 739 468 526 521
Total Expenditure 393 377 370 514 348 404 397
Operating Profit 137 124 109 225 121 122 124
Interest 1 0 0 0 0 0 0
Depreciation 9 9 9 10 9 9 10
Exceptional Income / Expenses 0 0 0 -27 -19 0 8
Profit Before Tax 127 115 99 188 92 113 122
Provision for Tax 46 34 30 52 24 30 31
Profit After Tax 81 81 70 137 68 82 91
Adjustments 42 71 68 0 35 0 0
Profit After Adjustments 123 152 138 137 103 82 91
Adjusted Earnings Per Share 53.4 66 59.9 59.4 44.9 35.7 39.7

Sanofi India Profit & Loss

#(Fig in Cr.) Dec 2023 Dec 2024 TTM
Net Sales 1996 2013 2235
Other Income 62 17 20
Total Income 2058 2030 2254
Total Expenditure 1509 1523 1663
Operating Profit 549 507 592
Interest 2 2 0
Depreciation 37 37 38
Exceptional Income / Expenses 18 -38 -38
Profit Before Tax 529 431 515
Provision for Tax 164 118 137
Profit After Tax 365 314 378
Adjustments 238 100 35
Profit After Adjustments 603 413 413
Adjusted Earnings Per Share 262.1 179.7 179.7

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 1% 0% 0% 0%
Operating Profit CAGR -8% 0% 0% 0%
PAT CAGR -14% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -8% -3% -5% 5%
ROE Average 36% 44% 44% 44%
ROCE Average 46% 59% 59% 59%

Sanofi India Balance Sheet

#(Fig in Cr.) Dec 2023 Dec 2024
Shareholder's Funds 1015 861
Minority's Interest 0 0
Borrowings 0 0
Other Non-Current Liabilities 1153 1208
Total Current Liabilities 2535 2610
Total Liabilities 4703 4679
Fixed Assets 315 313
Other Non-Current Assets 1257 1349
Total Current Assets 3132 3018
Total Assets 4703 4679

Sanofi India Cash Flow

#(Fig in Cr.) Dec 2023 Dec 2024
Opening Cash & Cash Equivalents 1005 395
Cash Flow from Operating Activities 230 462
Cash Flow from Investing Activities 38 -19
Cash Flow from Financing Activities -878 -392
Net Cash Inflow / Outflow -610 50
Closing Cash & Cash Equivalent 395 284

Sanofi India Ratios

# Dec 2023 Dec 2024
Earnings Per Share (Rs) 262.13 179.7
CEPS(Rs) 174.39 152.35
DPS(Rs) 167 117
Book NAV/Share(Rs) 411.7 343.96
Core EBITDA Margin(%) 23.5 23.76
EBIT Margin(%) 25.58 20.97
Pre Tax Margin(%) 25.5 20.9
PAT Margin (%) 17.59 15.2
Cash Profit Margin (%) 19.35 16.98
ROA(%) 13.74 6.69
ROE(%) 52.72 36.1
ROCE(%) 72.06 46.16
Receivable days 19.77 31.98
Inventory Days 68.22 102.89
Payable days 63.52 130.04
PER(x) 30.78 34.06
Price/Book(x) 19.59 17.8
Dividend Yield(%) 2.07 1.91
EV/Net Sales(x) 9.09 6.85
EV/Core EBITDA(x) 33.06 27.17
Net Sales Growth(%) 168.75 0.86
EBIT Growth(%) 121.74 -18.35
PAT Growth(%) 133.79 -13.96
EPS Growth(%) 287.11 -31.45
Debt/Equity(x) 0 0
Current Ratio(x) 1.24 1.16
Quick Ratio(x) 0.97 0.96
Interest Cover(x) 311.88 288.6
Total Debt/Mcap(x) 0 0

Sanofi India Shareholding Pattern

# Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Promoter 60.4 60.4 60.4 60.4 60.4 60.4 60.4 60.4 60.4 60.4
FII 6.99 6.71 6.72 6.8 6.31 6.11 5.81 5.78 5.63 5.57
DII 19.21 19.46 19.66 21.69 22.51 22.88 22.59 22.62 22.71 23.02
Public 13.4 13.43 13.22 11.11 10.78 10.61 11.2 11.2 11.26 11.01
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 44%
  • Company is almost debt free.

Cons

  • Debtor days have increased from 63.52 to 130.04days.
  • Stock is trading at 17.2 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Sanofi India News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!